'Brain fog' more common in first year postmenopause

Article

A cross-sectional National Institutes of Health (NIH)-supported study published in Menopauseshows that changes in cognitive function associated with menopause aren’t linear and, in fact, decline is most common in the first year after the final menstrual period.

 

A cross-sectional National Institutes of Health (NIH)-supported study published in Menopauseshows that changes in cognitive function associated with menopause aren’t linear and, in fact, decline is most common in the first year after the final menstrual period.

The aims of the Rochester Investigation of Cognition Across Menopause were to determine if cognitive function differs across stages of reproductive aging and to evaluate whether hormones or menopausal symptoms predict cognition in perimenopause. The 117 middle-aged women enrolled were categorized by reproductive stage based on criteria from the Stages of Reproductive Aging Workshop, with 34 in late reproduction, 28 in early menopause, 41 in late menopause, and 14 in early postmenopause. Most were well educated and more than 90% of participants were white, with mean age of 48.7 years.

Using a battery of neuropsychological tests, 6 domains of cognition were assessed, including verbal learning, verbal memory, and motor function. Menopausal symptoms and serum levels of estradiol and follicle-stimulating hormone (FSH) were also evaluated and the participants rated their symptoms of depression and anxiety, and their overall health, on questionnaires.

Multivariate regression of the impact of menopausal stage and symptoms on cognition showed that decreases in attention/working memory, verbal learning (P=0.02), verbal memory (P=0.02), and fine motor speed (P=0.03) were most evident in the first year after the final menstrual period. Higher levels of estradiol and FSH were associated only with fine motor speed (P=0.02 for both) but no associations were found between menopausal symptoms and cognitive scores.

 

Recent Videos
Transforming cervical cancer protection with the BD Onclarity HPV Assay | Image Credit: linkedin.com
March of Dimes 2024 Report highlights preterm birth crisis | Image Credit: marchofdimes.org
Understanding and managing postpartum hemorrhage: Insights from Kameelah Phillips, MD | Image Credit: callawomenshealth.com
Rossella Nappi, MD, discusses benefits of fezolinetant against vasomotor symptoms | Image Credit: imsociety.org
How AI is revolutionizing breast cancer detection | Image Credit: simonmed.com
Understanding cardiovascular risk factors in women | Image Credit: cedars-sinai.org.
Related Content
© 2024 MJH Life Sciences

All rights reserved.